Clinical Relevance of Plasma Prostaglandin F2α Metabolite Concentrations in Patients with Idiopathic Pulmonary Fibrosis
Open Access
- 11 June 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6), e66017
- https://doi.org/10.1371/journal.pone.0066017
Abstract
Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease of unknown etiology with few current treatment options. Recently, we determined an important role of prostaglandin F2α (PGF2α) in pulmonary fibrosis by using a bleomycin-induced pulmonary fibrosis model and found an abundance of PGF2α in bronchoalveolar lavage fluid of IPF patients. We investigated the role of PGF2α in human IPF by assessing plasma concentrations of 15-keto-dihydro PGF2α, a stable metabolite of PGF2α. We measured plasma concentrations of 15-keto-dihydro PGF2α in 91 IPF patients and compared these values with those of controls (n = 25). We further investigated the relationships of plasma 15-keto-dihydro PGF2α concentrations with disease severity and mortality. Plasma concentrations of 15-keto-dihydro PGF2α were significantly higher in IPF patients than controls (pRs [correlation coefficient] = −0.34, p = 0.004), forced vital capacity (Rs = −0.33, p = 0.005), diffusing capacity for carbon monoxide (Rs = −0.36, p = 0.003), the composite physiologic index (Rs = 0.40, p = 0.001), 6-minute walk distance (Rs = −0.24, p = 0.04) and end-exercise oxygen saturation (Rs = −0.25, p = 0.04) when patients with emphysema were excluded. Multivariate analysis using stepwise Cox proportional hazards model showed that a higher composite physiologic index (relative risk = 1.049, p = 0.002) and plasma 15-keto-dihydro PGF2α concentrations (relative risk = 1.005, p = 0.002) were independently associated with an increased risk of mortality. We demonstrated significant associations of plasma concentrations of PGF2α metabolites with disease severity and prognosis, which support a potential pathogenic role for PGF2α in human IPF.Keywords
This publication has 34 references indexed in Scilit:
- Integrating mechanisms of pulmonary fibrosisThe Journal of Experimental Medicine, 2011
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Basic Science of Pulmonary Arterial Hypertension for CliniciansCirculation, 2010
- Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis: A Population-Based StudySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2010
- Eicosanoid Lipid Mediators in Fibrotic Lung Diseases: Ready for Prime Time?Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2008
- Fleischner Society: Glossary of Terms for Thoracic ImagingRadiology, 2008
- Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Incidence of Pulmonary Hypertension and Its Clinical Relevance in Patients With SarcoidosisSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2006
- The Clinical Course of Patients with Idiopathic Pulmonary FibrosisAnnals of Internal Medicine, 2005
- Prostaglandin production by type II alveolar epithelial cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979